Cargando…

Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome

PURPOSE: Diabetes, as a group of metabolic diseases, can elevate blood glucose, thus leading to the development of life-threatening complications. It is difficult to define the outcome for diabetics with different BMI. This review will illustrate the adipose tissue macrophage-derived exosome in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaojie, Chu, Haichen, Ji, Yuzhi, Bosnjak, Zeljko, Ao, Hushan, Li, Tianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763208/
https://www.ncbi.nlm.nih.gov/pubmed/35046685
http://dx.doi.org/10.2147/DMSO.S345890
_version_ 1784633890107817984
author Liu, Xiaojie
Chu, Haichen
Ji, Yuzhi
Bosnjak, Zeljko
Ao, Hushan
Li, Tianjun
author_facet Liu, Xiaojie
Chu, Haichen
Ji, Yuzhi
Bosnjak, Zeljko
Ao, Hushan
Li, Tianjun
author_sort Liu, Xiaojie
collection PubMed
description PURPOSE: Diabetes, as a group of metabolic diseases, can elevate blood glucose, thus leading to the development of life-threatening complications. It is difficult to define the outcome for diabetics with different BMI. This review will illustrate the adipose tissue macrophage-derived exosome in the diabetics with different BMI. PATIENTS AND METHODS: Insulin resistance in peripheral tissues can cause diabetes. The peripheral tissues include liver, muscle, or the adipose depots. Communication between these organs is fatal to the maintenance of glucose homeostasis. This review will illustrate this communication. Obesity is closely linked with diabetes. There are different changes in fat distribution in diabetic patients. Adipose tissue macrophages can secrete various hormones, including adiponectin, leptin, resistin and other classical cytokines, such as TNF-α and IL-6. Studies illustrated that exosomes from the adipose tissue, can modulate inter-organ cross-talk by regulating gene expression in other tissues. RESULTS: Adipose tissue macrophages exosomes links thin and fat individuals in the development of diabetes. CONCLUSION: The molecular pathways initiated by exosomes such as miRNA in the situations of metabolic stress could help us gain a deeper knowledge of the pathophysiology of diabetes.
format Online
Article
Text
id pubmed-8763208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87632082022-01-18 Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome Liu, Xiaojie Chu, Haichen Ji, Yuzhi Bosnjak, Zeljko Ao, Hushan Li, Tianjun Diabetes Metab Syndr Obes Review PURPOSE: Diabetes, as a group of metabolic diseases, can elevate blood glucose, thus leading to the development of life-threatening complications. It is difficult to define the outcome for diabetics with different BMI. This review will illustrate the adipose tissue macrophage-derived exosome in the diabetics with different BMI. PATIENTS AND METHODS: Insulin resistance in peripheral tissues can cause diabetes. The peripheral tissues include liver, muscle, or the adipose depots. Communication between these organs is fatal to the maintenance of glucose homeostasis. This review will illustrate this communication. Obesity is closely linked with diabetes. There are different changes in fat distribution in diabetic patients. Adipose tissue macrophages can secrete various hormones, including adiponectin, leptin, resistin and other classical cytokines, such as TNF-α and IL-6. Studies illustrated that exosomes from the adipose tissue, can modulate inter-organ cross-talk by regulating gene expression in other tissues. RESULTS: Adipose tissue macrophages exosomes links thin and fat individuals in the development of diabetes. CONCLUSION: The molecular pathways initiated by exosomes such as miRNA in the situations of metabolic stress could help us gain a deeper knowledge of the pathophysiology of diabetes. Dove 2022-01-13 /pmc/articles/PMC8763208/ /pubmed/35046685 http://dx.doi.org/10.2147/DMSO.S345890 Text en © 2022 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Liu, Xiaojie
Chu, Haichen
Ji, Yuzhi
Bosnjak, Zeljko
Ao, Hushan
Li, Tianjun
Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
title Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
title_full Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
title_fullStr Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
title_full_unstemmed Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
title_short Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
title_sort which bmi for diabetes patients is better? from the view of the adipose tissue macrophage-derived exosome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763208/
https://www.ncbi.nlm.nih.gov/pubmed/35046685
http://dx.doi.org/10.2147/DMSO.S345890
work_keys_str_mv AT liuxiaojie whichbmifordiabetespatientsisbetterfromtheviewoftheadiposetissuemacrophagederivedexosome
AT chuhaichen whichbmifordiabetespatientsisbetterfromtheviewoftheadiposetissuemacrophagederivedexosome
AT jiyuzhi whichbmifordiabetespatientsisbetterfromtheviewoftheadiposetissuemacrophagederivedexosome
AT bosnjakzeljko whichbmifordiabetespatientsisbetterfromtheviewoftheadiposetissuemacrophagederivedexosome
AT aohushan whichbmifordiabetespatientsisbetterfromtheviewoftheadiposetissuemacrophagederivedexosome
AT litianjun whichbmifordiabetespatientsisbetterfromtheviewoftheadiposetissuemacrophagederivedexosome